Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 22
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Viemed Healthcare Inc
VMD
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$9.92
0.17
1.74%
Dern. MÀJ: Oct 21, 4:00 PM
$9.75
N/A
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Résultats:
Résultats Q3 2026 dans dans 13 jours à partir de maintenant le mer. nov. 4th, après la fermeture du marché
Viemed Healthcare Financials
Viemed Healthcare (VMD) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $312.000M-$320.000M to $314.000M-$320.000M vs $317.300M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $312.000 million-$320.000 million to $314.000 million-$320.000 million vs $317.300 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q2 EPS $0.07 Misses $0.12 Estimate, Sales $78.097M Miss $78.100M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 12.5 percent decrease over earnings of $0.08 per share from
Benzinga Newsdesk
PRO
Viemed Healthcare Raises FY2026 Sales Guidance from $310.000M-$320.000M to $312.000M-$320.000M vs $315.450M Est
Viemed Healthcare (NASDAQ:VMD) raises FY2026 sales outlook from $310.000 million-$320.000 million to $312.000 million-$320.000 million vs $315.450 million estimate.
Benzinga Newsdesk
PRO
Viemed Healthcare Q1 EPS $0.06 Misses $0.09 Estimate, Sales $75.414M Beat $74.400M Estimate
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.09 by 33.33 percent. This is unchanged from the same period last year. The company reported
Benzinga Newsdesk
Earnings Scheduled For May 5, 2026
Benzinga Insights
PRO
Viemed Healthcare Sees FY2026 Sales $310.000M-$320.000M vs $332.550M Est.
Viemed Healthcare (NASDAQ:VMD) sees FY2026 sales of $310.000 million-$320.000 million vs $332.550 million analyst estimate.
Benzinga Newsdesk
